Delivery Order SPE2DB24D2010-SPE2DB26FZSD5
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Jardiance 10 mg tablets (90-count) with a ceiling value of $1,864.56. This firm fixed-price delivery order, with an ultimate completion date of October 27, 2025, represents a continuation of AmerisourceBergen's pharmaceutical supply support under its existing contract vehicle with DLA. The award was made through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Jardiance 10 mg tablets (90-count units) with a ceiling value of $5,543.64. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion by October 16, 2025, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) with a ceiling value of $10,280.04. This firm fixed-price delivery order, which has no set-aside designation, is scheduled for completion by November 3, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement action under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Jardiance 10 mg tablets (90-count packages) with a ceiling value of $4,171.18. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement. The contract specifies an ultimate completion date of November 3, 2025, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Jardiance 25 mg tablets (90-count) valued at $5,638.65. This competitively awarded, firm fixed-price delivery order is set to be completed by August 8, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Jardiance 10 mg tablets (90-count units) with a contract ceiling value of $23,977.17. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The order is scheduled for completion by August 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Jardiance 10 mg tablets (90-count packages) with a contract ceiling value of $7,330.39. This competitively awarded, non-set-aside delivery order carries a firm fixed price structure and is scheduled for completion by May 7, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Jardiance 10 mg tablets (90-count) with a ceiling value of $10,745.91. This firm fixed-price delivery order is set to be completed by August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made on a non-set-aside, competitive basis. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $23,138.28 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on October 20, 2025, with an ultimate completion date of October 21, 2025. This competitive, non-set-aside award is structured as a firm fixed-price delivery order under an indefinite delivery contract vehicle. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 12, 2025, for the supply of Jardiance 10 mg tablets in quantities of 90 units, with a ceiling value of $3,136.98. This contract employs firm fixed-price pricing and is scheduled for completion by June 13, 2025. The award is unset-aside and represents a competitively awarded delivery order under AmerisourceBergen's existing federal procurement framework. The place of performance is located in...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB26FZSD5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Jardiance 10 mg tablets (90-count units) under a firm fixed-price contract with a ceiling value of $11,531.50. The delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by November 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, supplies a broad portfolio of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive contract portfolio with the DLA demonstrates its capability to fulfill federal medical procurement requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. This award reflects AmerisourceBergen's ongoing role as a primary supplier within the federal military medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.5k | 10/31/25 |